MyMD Pharmaceuticals, Inc. Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MyMD Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MyMD Pharmaceuticals, Inc. for January 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 3.02 | 8,000 | 24,160 | 269,243 | 261.2 K to 269.2 K (+3.06 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 3.08 | 2,700 | 8,316 | 261,243 | 258.5 K to 261.2 K (+1.04 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 3.07 | 7,500 | 23,025 | 258,043 | 250.5 K to 258 K (+2.99 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 3.03 | 3,000 | 9,090 | 251,043 | 248 K to 251 K (+1.21 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 3.07 | 5,000 | 15,350 | 248,043 | 243 K to 248 K (+2.06 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 3.02 | 6,000 | 18,120 | 243,043 | 237 K to 243 K (+2.53 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 2.98 | 20,600 | 61,388 | 237,043 | 216.4 K to 237 K (+9.52 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 3.05 | 6,019 | 18,358 | 216,443 | 210.4 K to 216.4 K (+2.86 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 3.10 | 26,406 | 81,859 | 210,424 | 184 K to 210.4 K (+14.35 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 2.97 | 30,000 | 89,100 | 184,018 | 154 K to 184 K (+19.48 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 2.99 | 50,000 | 149,500 | 154,018 | 104 K to 154 K (+48.07 %) |
Jan 07 2020 | AKER | Akers Biosciences, ... | Hudson Bay Capital Management ... | 10% Owner | Buy | P | 2.96 | 19,353 | 57,285 | 104,018 | 84.7 K to 104 K (+22.86 %) |
Jan 03 2020 | AKER | Akers Biosciences, ... | Schreiber Christopher C | Executive Chairman | Option Exercise | M | 0.00 | 5,201 | 0 | 0 | |
Jan 03 2020 | AKER | Akers Biosciences, ... | Schreiber Christopher C | Executive Chairman | Buy | M | 0.00 | 5,201 | 0 | 5,201 | 0 to 5.2 K |
Jan 03 2020 | AKER | Akers Biosciences, ... | White Billy Joe | Director | Option Exercise | M | 0.00 | 5,201 | 0 | 0 | |
Jan 03 2020 | AKER | Akers Biosciences, ... | White Billy Joe | Director | Buy | M | 0.00 | 5,201 | 0 | 5,201 | 0 to 5.2 K |
Jan 03 2020 | AKER | Akers Biosciences, ... | Silverman Joshua | Director | Option Exercise | M | 0.00 | 5,201 | 0 | 0 | |
Jan 03 2020 | AKER | Akers Biosciences, ... | Silverman Joshua | Director | Buy | M | 0.00 | 5,201 | 0 | 5,201 | 0 to 5.2 K |